Hematologic Issues in Cervical Spine Surgery

  • Giuseppe AvvisatiEmail author
  • Ombretta Annibali
  • Elisabetta Cerchiara
  • Marianna De Muro
  • Rosa Greco
  • Francesco Marchesi
  • Carolina Nobile
  • Odoardo Olimpieri
  • Azzurra Romeo
  • Maria Cristina Tirindelli
Anemia is defined as a reduction of hemoglobin (Hb) levels of <13 g/dL for a man and <12 g/dL for a woman. It is very frequent among hospitalized patients and can be a serious problem in patients who undergo cervical spine surgery. Anemia can be classified as:
  • Mild (Hb: >10 g/dL)

  • Moderate (Hb: 8–10 g/dL)

  • Severe (Hb: 6–8 g/dL)

  • Very severe (Hb: <6 g/dL)

To identify the causes of anemia, we can use functional and morphologic criteria. However, from a practical point of view, the morphologic criteria are preferred and require the reticulocytes absolute number and the mean corpuscular volume (MCV), respectively. The flowchart for identifying the causes of anemia using morphologic criteria is reported in Fig. 2.1.


Multiple Myeloma Essential Thrombocythemia Cervical Spine Surgery Lytic Bone Lesion Elective Spinal Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Marks PW, Glader B (2005) Approach to anemia in the adult and child. In: Hoffman R, Benz AI jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P (eds) Hematology, basic principles and practice, 4th edn. Elsevier, Churchill Livingstone, Amsterdam, New YorkGoogle Scholar
  2. 2.
    Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352:1011–1023PubMedCrossRefGoogle Scholar
  3. 3.
    Bergqvist D (2007) Risk of venous thromboembolism in patients undergoing cancer surgery and options for thrombo-prophylaxis. J Surg Oncol 95:167–174PubMedCrossRefGoogle Scholar
  4. 4.
    Ruggeri M, Rodeghiero F, Tosetto A et al; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Chronic Myeloproliferative Diseases Working Party (2008) Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. Blood 111:666–671PubMedCrossRefGoogle Scholar
  5. 5.
    Palmblad JE, Von dem Borne AE (2002) Idiopathic, immune, infectious and idiosyncratic neutropenias. Semin Hematol 39:113–120PubMedCrossRefGoogle Scholar
  6. 6.
    Kipps TJ (1995) Lymphocytosis and Lymphocytopenia. In. Beutler E, Lichtman MA, Coller BS, Kipps DJ (eds) Williams hematology. Mc Graw Hill, New YorkGoogle Scholar
  7. 7.
    Buckley MF, James JW, Brown DE et al (2000) A novel approach to the assessment of variations in the human platelet count. Thromb Haemost 83:480–484PubMedGoogle Scholar
  8. 8.
    Schafer AI (2004) Thrombocytosis. N Engl J Med 350:1211–1219PubMedCrossRefGoogle Scholar
  9. 9.
    Messinezy M, Westwood N, Sawyer B et al (1994) Primary thrombocythaemia: a composite approach to diagnosis. Clin Lab Haematol 16:139–148PubMedCrossRefGoogle Scholar
  10. 10.
    Vannucchi AM, BarbuiT (2007) Thrombocytosis and thrombosis. Hematology Am Soc Hematol Educ Program 363–370Google Scholar
  11. 11.
    George JN, Woolf SH, Raskob GE et al (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40PubMedGoogle Scholar
  12. 12. (Last revision 4 June 2007)
  13. 13.
    International Myeloma Working Group (2003) The International Myeloma Working Group criteria for the clas-sification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749–757CrossRefGoogle Scholar
  14. 14.
    Lord RS (1973) Vertebrobasilar ischaemia and the extracra-nial arteries. Med J Aust 7:32–37Google Scholar
  15. 15.
    Hayward CPM, Rao AK, Cattaneo M (2006) Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 12:128–136PubMedCrossRefGoogle Scholar
  16. 16.
    Shen Y-M, Frenkel E (2007) Acquired platelet dysfunction. Hematol Oncol Clin N Am 21:647–661CrossRefGoogle Scholar
  17. 17.
    Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330:1287–1293PubMedCrossRefGoogle Scholar
  18. 18.
    Hirsh J, Dalen JE, Fuster V et al (1995) Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects. Chest 108:247–257CrossRefGoogle Scholar
  19. 19.
    Antman EM, Benett JS, Daugherty A et al (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115:1634–1642PubMedCrossRefGoogle Scholar
  20. 20.
    Jacobson AK (2004) Platelet ADP receptor antagonists: ticlopidine and clopidogrel. Best Pract Res Clin Haematol 17:55–64PubMedCrossRefGoogle Scholar
  21. 21.
    Reding MT (2005) Hematologic problems in the surgical patient: bleeding and thrombosis. In: Hoffman R, Benz AI jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P (eds) Hematology, basic principles and practice, 4th edn. Elsevier, Churchill Livingstone, Amsterdam, New YorkGoogle Scholar
  22. 22.
    Kitchen S, Makris M (2005) Laboratory tests of hemostasis. In: O'Shaughnessy D, Makris M, Lillicrap D (eds) Practical hemostasis and thrombosis. Blackwell, USAGoogle Scholar
  23. 23.
    Ageno W, Squizzato A, Garcia D et al (2006) Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 32:651–658PubMedCrossRefGoogle Scholar
  24. 24.
    Mazzolai L, Duchosal MA (2007) Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening. Eur J Vasc Endovasc Surg 34:483–488PubMedCrossRefGoogle Scholar
  25. 25.
    Simioni P, Tormene D, Spiezia L (2006) Inherited thrombo-philia and venous thromboembolism. Semin Thromb Hemost 32:700–708PubMedCrossRefGoogle Scholar
  26. 26.
    Epstein NE (2005) A review of the risk and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol 64:295–302PubMedCrossRefGoogle Scholar
  27. 27.
    Brambilla S, Ruosi C, La Maida GA et al (2004) Prevention of venous thromboembolism in spinal surgery. Eur Spine J Feb; 13(1):1–8CrossRefGoogle Scholar
  28. 28.
    Geerts WH, Bergqvist D, Pineo GF, Heit JA et al (2008) Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edn). Chest 133:381S–453SPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Giuseppe Avvisati
    • 1
    Email author
  • Ombretta Annibali
    • 2
  • Elisabetta Cerchiara
    • 2
  • Marianna De Muro
    • 2
  • Rosa Greco
    • 2
  • Francesco Marchesi
    • 2
  • Carolina Nobile
    • 2
  • Odoardo Olimpieri
    • 2
  • Azzurra Romeo
    • 2
  • Maria Cristina Tirindelli
    • 2
  1. 1.Hematology, University Campus Bio-MedicoRomeItaly
  2. 2.Department of HematologyUniversity Campus Bio-MedicoRomeItaly

Personalised recommendations